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Abstract
Background: Walnut is unique because they have a perfect balance of n-6 and n-3 polyunsaturated fatty acids.
The increasing market demand of walnut lipids results in the large amount of the oil extraction residue. The walnut
residue is rich in nutritional proteins, and the uneconomic use of the by-product discouraged the development of
walnut industry. Anticancer peptides have recently received attention as alternative chemotherapeutic agents that
overcome the limits of current drugs. The aim of this study was to investigate whether anticancer bioactive peptide
is contained in walnut.
Methods: Walnut residual protein was hydrolyzed separately by five different proteases. The sequential purification
of the hydrolysates was carried out by ultra-filtration, gel filtration chromatography and RP-HPLC to obtain a cancer
cell growth inhibitory peptide. Cell cycle distribution, Annexin V-FITC/PI double staining, TUNEL assay, western blot and
immunofluorescence for LC3-II assay were used to detect apoptosis and autophagy on cells. Cytokine production was
measured by ELISA kits, macrophage phagocytosis was measured by neutral red uptake assay, nitric oxide production
was measured by Griess reagent.
Results: The hydrolysates of walnut residual protein produced by papain under the optimal conditions (5 % substrate
concentration and an enzyme-substrate ratio of 10 % at temperature 60 C for 3 h), showed significant growth inhibitory
activity on MCF-7. The amino acid sequence of the purified peptide was identified as CTLEW with a molecular weight of
651.2795 Da. It is a novel bio-peptide with an amphiphilic structure. CTLEW induced both apoptosis and autophagy on
MCF-7 cells, inhibited the cancer cells growth of Caco-2 and HeLa significantly, but did not show any cytotoxic activity
against non-cancerous IEC-6 cells. Moreover, the bio-peptide enhanced proliferation and IL-2 secretion of spleen
lymphocytes, promoted phagocytosis and NO production of macrophages.
Conclusion: These results suggested that a novel bio-peptide, CTLEW inducing apoptosis and autophagy on MCF-7 cells
can be released from walnut residual protein through papain hydrolyzing under the certain condition. The bio-peptide
shows selective inhibition towards cancer cells growth and immunomodulatory activity.
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Background
Walnut (Juglans regia L.) is the most widespread tree nut
in the world, which has been reported with keratolytic, an-
tifungal, hypoglycemic, hypotensive, anti-oxidant, and
sedative activities [1, 2]. Walnut is nutrient-dense food,
mainly owing to its fat content as well as protein, vitamin
and mineral profiles. Walnut is unique because they have a
perfect balance of n-6 and n-3 polyunsaturated fatty acids,
a ratio of 4:1, which has been shown to decrease the inci-
dence of cardiovascular risk. Thus, walnut oil is extracted
in large quantities. The increasing market demand of wal-
nut lipids results in the large amount of the oil extraction
residue. The walnut residue is rich in nutritional proteins,
450 g/kg on average [3]. However, it is used as forage usu-
ally, and the uneconomic use of the by-product discour-
aged the development of walnut industry. It is essential to
improve the economic value of the walnut by-products [4],
while elucidating the biological activities of the walnut pro-
tein are generally thought to be beneficial for effectively
utilizing the by-product of walnut. Walnut protein has been
reported to have antioxidant effect and can inhibit the ac-
tivity of angiotensin I-converting enzyme (ACE), a dipepti-
dyl carboxypeptidase associated with the regulation of
blood pressure as well as cardiovascular function [2, 5].
However, whether it has anticancer function is unknown.
Cancer is a major cause of mortality worldwide and can-
cer incidents has been rapidly increasing in recent years.
The use of conventional chemotherapeutic agents that
typically target rapidly dividing cancer cells is often associ-
ated with deleterious side effects due to drug-induced dam-
age to normal cells and tissues [6]. Moreover, cancer cells
develop resistance to these drugs that is mediated by the
over expression of multidrugresistance proteins that pump
the drugs out of cells and thus render the drugs ineffective
[7]. Therefore, the research and development of more
effective and less toxic anticancer agents has become ne-
cessary. Anticancer peptides have recently received
attention as alternative chemotherapeutic agents that over-
come the limits of current drugs. A growing body of evi-
dence has shown that peptides from milk and soy proteins
can prevent cancer [8, 9]. Anticancer effects also have been
demonstrated in enzymatic protein hydrolysates (or pep-
tides) of rapeseed, solitary tunicate and rice bran [10–12].
A 440.9 Da anchovy hydrophobic peptide was found to be
able to induce apoptosis in human U937 lymphoma cells
by increasing caspase-3 and caspase-8 activity [13].
Epinecidin-1, a peptide from fish (Epinephelus coioides)
showed an antitumor effect similar to lytic peptides in hu-
man fibrosarcoma cells [14]. Whether anticancer bioactive
peptide is contained in the walnut was not reported yet.
Peptides generated by the digestion of various pro-
teins, from both animal and plant sources, possess bio-
functional activity. These peptides are inactive within
the sequences of their parent proteins and are released
by proteolytic hydrolysis using commercially available
enzymes or proteolytic microorganisms and fermenta-
tion methods [15, 16]. For instance, antioxidant peptides
isolated from rapeseed proteins 3 and angiotensin-I-
converting enzyme (ACE) inhibitory peptides Gly-Pro-
Leu and Gly-Pro-Met extracted from the skin of Thera-
gra chalcogramma 4 are natural peptides [17]. Once
such bioactive peptides are liberated depending on their
structural, compositional, and sequential properties, they
may exhibit various biofunctional activities,because bio-
active peptides can be absorbed in the intestine and
enter the blood stream directly, which ensures their bio-
availability in vivo and a physiological effect at the target
site [17]. Different enzymes give the hydrolysates differ-
ent qualities and bioactivities, since enzymes have spe-
cific cleavage positions on polypeptide chains, protein
hydrolysates prepared with different enzymes exhibit dif-
ferent amino acid sequences and peptide lengths [18].
For example, walnut protein showed potent antioxidant
activity after being hydrolyzed by pepsin [2], while it will
reveal significant ACE inhibitory activity by neutral pro-
teinase [5]. Various parameters also play a great role in
hydrolyzing protein, such as Temperature, time, enzyme-
substrate ratio and substrate concentration. Study on how
to prepare the walnut protein hydrolysate with anticancer
activity has not been reported so far.
In the present study, walnut residual protein was hydro-
lyzed separately by five different proteases to find a suit-
able enzyme which can release anticancer peptides, and
then the hydrolysis condition of this enzyme on the wal-
nut residual protein was optimized. Anticancer peptide
was isolated from the walnut residual protein hydrolysate
prepared under the optimal condition, identified on the
basis of analyzing the key marker of cancer cells prolifera-
tion, and elucidated the possible mechanism underlying
the activity on the breast cancer cell model, MCF-7.
Methods
Materials and chemicals
Walnuts were obtained from Hebei Jingpin Fruits Co.,
Ltd (Hebei, P.R. China). Proteases were purchased from
Sigma-Aldrich Co. (St. Louis, MO, USA). Cell lines of
MCF-7 (human breast cancer cell line), Caco-2 (human
colon cancer cells), Hela (human cervical cancer cells)
and IEC-6 (rat small intestinal crypt epithelial cells) were
obtained from the Cell Culture Centre of the Institute of
Basic Medical Sciences, Chinese Academy of Medical
Sciences (Beijing, P.R. China).
Preparation of different walnut residual protein
hydrolysates
Walnuts were ground and defatted with petroleum
ether. The defatted flour was dried in the drying oven
overnight at 50 °C as walnuts oil extraction residue.
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Walnut residual protein (WRP) was extracted from
walnuts oil extraction residue by NaOH solution
(pH 9.0) at ratio 1:15 (w/v) for 1 h (45 °C). After pH
adjustment to 4.5, the precipitate obtained by centri-
fugation at 4000 × g for 15 min and the supernatants
were lyophilized. The protein hydrolysates were pre-
pared with alkaline protease, papain, pepsin, trypsin
and neutral protease, respectively. WRP was dissolved
in distilled water at a concentration of 30 mg/ml and
hydrolyzed for 3 h separately using alkaline protease
at pH 9.0, 50 °C, papain at pH 7.0, 60 °C, pepsin at
pH 2.5, 37 °C, trypsin at pH 8.0, 40 °C and neutral
protease at pH 7.5, 55 °C. Samples were taken out
after 3 h and heated in a boiling water bath at 95 °C
for 10 min to inactive enzyme’activity. The samples
were then centrifuged at 4000 × g for 15 min and the
supernatants were lyophilized.
Ultrafiltration
The protein hydrolysates were sequentially filtered through
cellulose membranes (Ultrafiltration system Millipore,
Bedford, Mass., USA) with molecular weight cutoffs
(MWCO) of 10, 5, and 3 kDa (Millipore). Peptide fractions
derived from walnut protein hydrolysates were: 10–5 kDa,
5–3 kDa and < 3 kDa fraction, respectively. All permeates
were lyophilized and stored at −20 °C until further
analysis.
Cell culture
MCF-7 and Hela cells were grown in Dulbecco’s Modified
Eagle’s Medium (DMEM) (Gibco, Rockville, MD, USA)
containing 10 % heat-inactivated fetal calf serum (FCS)
(Hyclone) and 0.5 % penicillin/streptomycin at 37 °C in a
humidified atmosphere containing 5 % CO2. Caco-2 and
IEC-6 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM, Gibco, Rockville, MD, USA))
supplemented with 10 % FCS (Hyclone), 0.1 mM nones-
sential amino acid, 0.5 % penicillin/streptomycin at 37 °C
in a humidified atmosphere containing 5 % CO2.
Cell Viability Assay
Cell viability was assessed by MTT assay [19]. Briefly, cells
were seeded into 96-well microplates at a density of 3 × 104
cells per well. After overnight incubation, cells were treated
with various concentrations of samples and cultured for
48 h. After incubation, 20 μl of MTT (3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyl-tetrazolium bromide, 5 mg/mL)
reagent was added to each well and incubated for 4 h at
37 °C in the dark. The culture medium containing the
MTT solution was replaced by 200 μL DMSO (dimethyl
sulfoxide) and shaken in the dark for 15 min at room
temperature for complete dissolution of the MTT forma-
zan productions. The optical density of each well was mea-
sured by absorbance at 570 nm using a Benchmark Plus
microplate reader (Bio-Rad, Hercules, USA). The cell
viability and inhibitory rate was calculated as follows: Cell
Viability (%) = b/a × 100; Inhibitory Rate (%) = [(a − b)/a] ×
100, Where a is the optical density without sample, and b
is the optical density in the presence of sample. The IC50
value is the concentration that inhibits 50 % of the cell
viability.
Gel filtration chromatography
The fraction with the highest antioxidant activity after
ultrafiltration separation was re-dissolved in phosphate
buffer(pH 7.0), then separated using a HiPrep 16/60
Sephacryl S-100HR column (16 × 600 mm, Amersham
Pharmacia Biotech, Piscataway, NJ, USA) which was
eluted with phosphate buffer at a flow of 1.0 ml/min, and
monitored at 280 nm. The fractions with the desired
peaks were pooled, desalted using a HiPrep™ 26/10 desalt-
ing column (Amersham Pharmacia Biotech, Piscataway,
NJ, USA) and lyophilized for MTTassay.
RP-HPLC
The fraction exhibiting the highest cytotoxic activity after
gel filtration chromatography was further purified on a
Zorbax SB-C18 (250 mm× 4.6 mm,5 um,Agilent,USA).
The column was eluted by a linear gradient of acetonitrile
(0-40 %) containing 0.1 % Trifluoroacetic acid (TFA) at a
flow rate of 1.0 ml/min. The eluted peaks were detected at
214 nm and the fraction was then lyophilized.
Molecular mass and amino acid sequence analysis
Accurate molecular mass and amino acid sequence of the
active peptide was determined by Hybrid Quadrupole
TOF-LC/MS/MS mass spectrometer (AB Sciex Instru-
ments, CA, USA) coupled with ESI source. Generally, the
peptide was infused into electrospray source following
dissolve in acetonitrile/water (1:1, v/v), and molecular mass
was determined by charged (M+H)+ state in the mass
spectrum. Following molecular mass determination and
sequence information was obtained by BioLynx analysis
system.
Simulated gastrointestinal digestion of bioactive peptides
The pH of the sample was adjusted to pH 2.0 by 1 N HCl,
and the mixture was incubated with pepsin at 800 U/mL
in a shaking bath for 2 h at 37 C with shaking at 100 rpm.
The sample was then neutralized with 1 M NaOH to
pH 7.0 before addition of pancreatin at 2 mg/mL and bile
extract mixtureat 0.3 mg/mL for a further incubation of
2 h. Finally, the digestion was terminated by boiling for
10min [20].
Cell cycle distribution analysis
MCF-7 cells were treated with or without test sample
for 48 h. Cells were harvested fixed with cold ethanol/
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destillata (3:1, v/v) at 4 °C overnight. Before analysis,
cells were washed with PBS and stained with a solution
containing 100 μL propidium iodide, 100 μg/mL RNase
at 37 °C for 30 min in the dark. The fluorescence of
stained cells was analyzed by flow cytometry using a
FACSCanto (Becton-Dickinson, CA, USA).
Annexin V-FITC/PI double staining assay
Apoptosis can be detected by translocation of phosphati-
dyl serine to the cell surface using an annexin V-FITC
antibody. MCF-7 cells were seeded in 6-well plates by
density of 3 × 104 cells/ml. Cells were treated with or with-
out test sample for 48 h. The cells were counted after tryp-
sinization and washed twice with cold PBS. The cell pellet
was resuspended in 100 μl of binding buffer (10 mM
HEPES, pH 7.4, 140 mM NaCl, and 2.5 mM CaCl2) at a
density of 1 × 105 cells per ml and incubated with 5 μl of
FITC-conjugated Annexin-V and 10 μl of propidium
iodide (PI) for 15 min at room temperature in the dark.
Annexin V-FITC and PI fluorescence was monitored by
flow cytometry (FACSAria, Becton–Dickinson, CA, USA).
Cells that stained positive for Annexin V were classified as
early apoptotic cells; cells positive for both PI and Annexin
V staining were classified as late apoptotic cells; and PI
and Annexin V negative cells were classified as live cells
[19].
TUNEL (TdT-mediated dUTP nick end labeling) assay
TUNEL technique has been extensively used for the de-
tection and quantification of apoptosis. MCF-7 cells
were cultured on coverslips and then fixed with station-
ary liquid (Anhydrous ethanol: chloroform: glacial acetic
acid 6: 3:1), and digested in proteinase K for 20 min at
37 °C, before endogenous peroxidase was blocked in 3 %
hydrogen peroxide. Terminal deoxynucleotidyl transfer-
ase (TdT) in reaction buffer (containing a fixed concen-
tration of digoxigenin-labelled nucleotides) was applied
to sections for 30 min at 37 °C, before the slides were
placed in Stop/Wash buffer for 10 min. Following
washes, a prediluted peroxidase conjugated antibody was
applied for 30 min. Apoptotic cells were detected after
incubation in the 3,3-diaminobenzidine (DAB) chromo-
gen for approximately 10 min and slides were counter-
stained with hematoxylin [21, 22].
Western blotting
MCF-7 cells were seeded in 6 cm dishes overnight and
incubated with test sample for the 48 h. Cells were
harvested by trypsinization and washed twice with cold
PBS. Total cellular protein lysates were prepared by
harvesting cells in protein extraction buffer (50 mM Tris–
HCl, pH 7.4, 1 mM NaF, 150 mM NaCl, 1 mM EGTA,
1 mM phenylmethanesulfonyl fluoride; 1 % NP-40; and
10 mg/mL leupeptin) to the cell pellets on ice for 30 min,
followed by centrifugation at 10,000 × g for 30 min at 4 °C.
Equal amounts of protein (50 mg) were separated by 10 %
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS-PAGE). After electrophoresis, proteins were electro-
blotted to nitrocellulose membranes, and subsequently
incubated in blocking buffer (in PBS, 5 % skim milk, and
0.1 % Tween 20) at room temperature for 2 h. After block-
ing, the membranes were incubated with the antibodies,
rabbit anti-LC3 I/II (1:800), and glyceraldehyde 3-
phosphate dehydrogenase (GAPDH, 1: 800). Subsequently,
membranes were washed five times in a wash buffer and
incubated with appropriate donkey anti-rabbit horseradish
peroxidase conjugated secondary antibody (1:8000), and
the bands were disposed with the Gel-Pro Analyzer 4.0
(Media Cybernetics, USA) [19, 23].
Immunofluorescence for LC3-II
MCF-7 cells were seeded on coverslips overnight and then
incubated with test sample or rapamycin (RAPA) for the
next 48 h. The cells fixed with 4 % (v/v) paraformaldehyde
for 30 min and then covered with 10 % (v/v) goat serum
for 60 min at room temperature followed by incubation
with primary antibody of LC3-II in 1: 200 dilution at 4 °C
overnight. Cells were then probed with Alexa Fluor 488-
goat anti-rabbit IgG secondary antibody (1:200, Invitrogen
Life Technologies, Carlsbad, CA, USA). Counterstaining
of cell nuclei was performed by Vectashield H-1200
mounting medium with DAPI. Fluorescent staining was
examined with a confocal fluorescence microscope (Nikon
EZ-C1, Nikon, Tokyo, Japan). [24–26].
Measurement of cytokine production
For cytokine immunoassays, Mouse spleen lymphocytes
were cultured for 24 h at a density of 1 × 106 cells/ml in
96-well plates. Supernatants were removed at the indi-
cated time, and IL-2 production was quantified by sand-
wich immunoassays using the protocol supplied by
ELISA kits (Beyotime Biotechnology, China).
Neutral red uptake assay for macrophage phagocytosis
Macrophages were prepared from Kunming mice as
described Chen et al. [27]. The phagocytic ability of
macrophage was measured by neutral red uptake. After
cells were cultured with test substances for 48 h, 100 μl
neutral red solutions (dissolved in 10 mM PBS with the
concentration of 0.075 %) was added and incubated for
1 h. The supernatant was discarded and the cells in 96-
well plates were washed with PBS twice to remove the
neutral red that was not phagocytized by RAW264.7
cells. Then cell lysate (ethanol and 0.01 % acetic acid at
the ratio of 1:1, 100 μl/ well) was added to lyse cells.
After cells were incubated in room temperature over-
night, the optical density at 540 nm was measured by a
micro-plate reader (Bio-Rad, Hercules, U.S.A.).
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Nitric oxide (NO) production by macrophages
Measurement of nitrite in medium was used as an indicator
of NO production. The macrophage cells (5 × 105 cells/ml)
were cultured in 96-well plates with test substances. After
24 h, culture supernatants were collected and nitrite, the
stable reaction product of NO with molecular oxygen, was
measured using Griess reagent. Equal volumes of Griess
reagent and sample were incubated together at room
temperature for 10 min. Nitrite production was determined
by comparing the absorbance at 540 nm with a standard
curve generated by NaNO2 [20, 28].
Statistical analysis
The data were expressed as means ± S.D. The
significance of difference was evaluated with one-way
ANOVA, followed by Student’s t- test to statistically
identify differences between the control and treated
groups. Significant differences were set at *p < 0.05,
**p < 0.01, and ***p < 0.001.
Results
Cytotoxic activity of walnut protein hydrolysates on
MCF-7 cells
To investigate whether anticancer bioactive peptide is
contained in walnut, WRP was hydrolyzed separately by
papain, pepsin, trypsin, neutral protease and alkaline pro-
tease as described above, and termed as WRPH-pa,
WRPH-pe, WRPH-tr, WRPH-np and WRPH-ap respect-
ively. The effect of walnut residual protein and the protein
hydrolysates on proliferation of MCF-7 cells was investi-
gated by MTT cell proliferation assay. As shown in Fig. 1,
the results indicated that the protein hydrolysates inhib-
ited cells growth, while WRP was inert. Among all hydro-
lysates, WRPH-pa showed significant cytotoxic activity in
a dose-dependent manner, and the IC50 value was
1.62 mg/ml after 48 h treatment, while the other four
different enzymatic protein hydrolysates (WRPH-pe,
WRPH-tr, WRPH-np and WRPH-ap) showed no obvious
inhibitory effect (Fig. 1). This result suggested that bio-
active peptide(s) with cytotoxic activity on the cancer cells
was (were) contained in walnut residual protein, and was
(were) released during papain hydrolysis.
Various parameters play a great role in the optimization
of the experimental conditions for hydrolyzing protein.
Temperature (T), time (t), enzyme-substrate ratio 330
(E/S) and substrate concentration (S) are generally
considered to be the most important factors that
affect protein hydrolysis. The investigated levels of
each factor were selected depending on the MTT cell
proliferation assay result of the single-factor (Fig. 2).
Independent variables with three variation levels, X1
(temperature: 55, 60, 65 h), X2 (time (t): 3, 4, and 5 h), X3
(substrate concentration: 3, 4, and 5 %) and X4 (enzyme-
substrate ratio: 8, 10, and 12 %) are presented in Table 1.
Orthogonal experimental design was implemented to
illustrate the effects of different factors involved in the
enzymatic hydrolysis. The results of the orthogonal test



















Fig. 1 Effects of walnut residual protein and the enzyme protein hydrolysates on MCF-7 cell proliferation. After treated with test substances (0.5,
1, 2, 3, 4 mg/ml) for 48 h, cell viability was measured by MTT assay. WRP, walnut residual protein; WRPH-pa, walnut residual protein hydrolysate
prepared with papain; WRPH-pe, walnut residual protein hydrolysate prepared with pepsin; WRPH-tr, walnut residual protein hydrolysate prepared
with trypsin; WRPH-np, walnut residual protein hydrolysate prepared with neutral protease; WRPH-ap, walnut residual protein hydrolysate prepared
with alkaline protease. Results were expressed as means ± S.D. of four separate experiments. Statistical significance test for comparison with control
(untreated) group was done by Student’s t-test. *p < 0.05; **p < 0.01; ***p < 0.001
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Fig. 2 Effect of WRPH-pa in different hydrolytic conditions on MCF-7 cell proliferation. a WRPH-pa was hydrolyzed at temperature of 50, 55, 60, 65
and 70 °C, respectively with the conditions of time 3 h, substrate concentration 4 % and an enzyme-substrate ratio 10 %. b WRPH-pa was hydrolyzed
at time of 1, 2, 3, 4 and 5 h, respectively with the conditions of temperature 60 °C, substrate concentration 4 % and an enzyme-substrate ratio 10 %.
c WRPH-pa was hydrolyzed at substrate concentrations of 2, 3, 4, 5 and 6 %, respectively with the conditions of temperature 60 °C, time 3 h and an
enzyme-substrate ratio 10 %. d WRPH-pa was hydrolyzed at enzyme-substrate ratio of 8, 9,10,11 and 12 %, respectively with the conditions of
temperature 60 °C, time 3 h and substrate concentration 4 %. WRPH-pa, walnut residual protein hydrolysate prepared with papain
Table 1 Results and analysis of the orthogonal test
No. A B C D IR (%)a
Temperature (°C) Time (h) S (%) E/S (%)
1 55 3 3 8 66.13 ± 0.78
2 55 4 4 10 69.57 ± 1.13
3 55 5 5 12 63.73 ± 1.83
4 60 3 4 12 66.41 ± 0.85
5 60 4 5 8 70.55 ± 0.69
6 60 5 3 10 68.21 ± 0.50
7 65 3 5 10 68.34 ± 2.15
8 65 4 3 8 60.53 ± 1.90
9 65 5 4 12 64.81 ± 1.79
K1 66.48 ± 2.94 66.96 ± 1.20 64.96 ± 3.97 65.74 ± 5.02
K2 68.39 ± 2.08 66.89 ± 5.52 66.93 ± 2.42 68.71 ± 0.75
K3 64.56 ± 3.91 66.58 ± 2.34 67.54 ± 3.48 65.98 ± 1.35
Best level 60 °C 3 h 5 % 10 %
R 3.67 0.60 1.82 3.88
R order D > A > C > B
aMCF-7 inhibitory rate
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are showed in Table 1. The factors affecting the cytotoxic
activity of WRPH-pa are listed in descending order accord-
ing to the range values (R): D >A >C > B. The enzyme-
substrate ratio used during the enzymolysis was found to
be the most important factor. The WRPH-pa with the
higher cytotoxic activity was prepared in the condition of
D2A2C3B1. These results indicated that walnut residual
protein hydrolysates with the higher cytotoxic activity on
MCF-7 cells could be prepared by papain in the condition
as follow: 5 % substrate concentration and an enzyme-
substrate ratio of 10 % at temperature 60 C for 3 h.
Identification of bioactive peptides with cytotoxic activity
on MCF-7 cells
The peptide length and molecular weight distribution of
hydrolysates were considered to be closely related to their
biological activities [29, 30]. In most cases, low or rela-
tively low molecular weight exhibited bioactivities [2, 11,
31, 32]. Peptides longer than 10 kD were found to have
less or no cytotoxic activity on cancer cell growth [12].
Ultrafiltration membrane with MWCO 3 kDa, MWCO
5 kDa, MWCO 10 kDa was used to separate the WRPH-
pa into three fractions, WRPH-pa1 (10–5 kDa), WRPH-
pa2 (5–3 kDa) and WRPH-pa3 (<3 kDa). WRPH-pa3 with
the lowest molecular weight showed the highest cytotoxic
activity among the three fractions (Fig. 3a). Compared
with the higher molecular weight peptides, the lower mo-
lecular weight peptides have greater molecular mobility
and diffusivity, which seems to promote interactions with
cancer cell components and improve anticancer activity
[33]. WRPH-pa3 exhibited the higher cytotoxic activity
was selected for further study. WRPH-pa3 was then sepa-
rated into five fractions(I-V) by gel filtration (Fig. 3b).
FractionVexhibited the higher cytotoxic activity(Fig. 3b
Inset). The active fraction was further fractionated on a
RPLC C18 column (Fig. 3c). Four fractions (A-D) were
collected separately. While all of the fractions showed the
cytotoxic activity, fraction C and D had the higher cyto-
toxic activity (Fig. 3c Inset). That is, the higher the hydro-
phobicity of peptides, the stronger the cytotoxicity against
MCF-7 cells. Fraction C had the highest cytotoxic activity
among the four fractions, the IC50 was 0.449 mg/ml
(Fig. 3c Inset). Fraction C was then rechromatographed
on RPLC C18 column. A single pure peptide was even-
tually obtained. The amino acid sequence of the pep-
tide was identifies as CTLEW (Cys-Thr-Leu-Glu-Trp),
and the peptide possesses a m/z value of 651.2795
(MH+, protonated mono isotopic mass) by TOF-LC/
MS/MS and BioLynx analysis system. (Fig. 3d and e)
The active peptide (CTLEW) managed to retain about
82.1 % of its original cytotoxic activity even after suc-
cessive digestion with pepsin, bile extract and pan-
creatin (data not shown). Following simulated gastric
and intestinal digestion, no significant difference was
found in cytotoxic activity, which would indicate that
the peptide CTLEW may survive in the process of
gastrointestinal transit. These results showed that the
bioactive peptide with cytotoxic activity on MCF-7
cells in walnut protein hydrolysates was a pentapep-
tide CTLEW with molecular weight of 651.2795 Da.
CTLEW Induced apoptotic and autophagic cell death
Since CTLEW significantly inhibited the proliferation
of MCF-7 cells, we then tried to investigate the pos-
sible mechanism underlying cytotoxic activity of
CTLEW on growth of MCF-7 cells. Cell cycle distri-
bution was analyzed by flow cytometry and apoptosis
was assessed by Annexin V FITC/ PI double-staining
and TUNEL assay. MCF-7 cells were treated with the
indicated concentration of CTLEW for 48 h. As
shown in Fig. 4, CTLEW significantly increased the
number of cells in sub-G1 phase to 7.67 or 18.24 %
compared with control (3.79 %) at the concentration
of 0.5 or 1.0 mg/ml. These results suggested that
CTLEW might be induced apoptosis of MCF-7 cancer
cells in a dose-dependent manner.
To determine apoptosis mediated the cytotoxicity of
CTLEW, the loss of phosphatidylserine asymmetry, a hall-
mark of apoptosis, was quantified by cytometry of propi-
dium iodide/Annexin V double-stained cells [26]. As
shown in Fig. 5a, Annexin V FITC/ PI double-staining
assay indicated that CTLEW induced phosphatidylserine
externalization without increasing the proportion of pro-
pidium iodide cells, implicating that CTLEW induced
apoptosis but not necrotic cell death. The total apoptosis
rates were 8.17 and 18.11 % (control, 4.07 %) in the cells
treated with CTLEW at the concentration of 0.5 and
1.0 mg/ml. Apoptosis was further confirmed by TUNEL
assay. Treating MCF-7 cells with various concentrations
of CTLEW (0.5 or 1.0 mg/ml) for 48 h, cell tissue slices
were observed by immunocytochemical staining, where
the labelled yellow brown nucleus represented the apop-
totic cells. As shown in Fig. 5b, apoptosis rate were 10
and 25 % (control, 5.0 %), respectively, in the cells
treated with CTLEW at the two concentrations. These
findings suggested that CTLEW induced apoptosis in a
dose-dependent manner.
To evaluate autophagic cell death induced by CTLEW,
LC3I/II was determined by western blot analysis. As shown
in Fig. 6a, CTLEW significantly increased the level of
phosphatidylethanolamine-conjugated LC3-II, whereas un-
conjugated LC3-I levels were slightly decreased. The result
indicated the activation of autophagic cell death in CTLEW
treated cells. Autophagy was further confirmed by im-
munofluorescence for LC3-II. Immunofluorescent staining
was observed with a confocal fluorescence microscope.
The activation of LC3II was revealed in the cytoplasm in
CTLEW -treated MCF-7 cells (Fig. 6b). Furthermore,
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LC3-II protein expression was increased remarkably upon
treatment with 1.0 mg/ml of CTLEW, which was compar-
able to that of RAPA, again suggesting the CTLEW -in-
duced cells autophagy (Fig. 6b). Taken together, these
results showed that CTLEW was able to induce apoptosis
and autophagy in MCF-7 cells.
Effect on different cell types and immunomodulatory
activity of CTLEW
To investigate effect of CTLEW on other cancer cells
and non-cancer cells, cell viability was measured by
MTT assay on Caco-2, Hela and IEC-6 cell lines respect-
ively, after treated with the active peptide for 48 h. As
shown in Table 2, the results indicated that CTLEW also
significantly inhibited proliferation of Caco-2 (IC50
value 0.65 ± 0.42 mg/ml) and Hela (IC50 value 0.60 ±
0.17 mg/ml). Interestingly, the peptide showed almost
no inhibition on the growth of IEC-6 (IC50 value
>4 mg/ml, the highest concentration treated cells was
4 mg/ml). These results showed that CTLEW could kill
cancer cells selectively, and was less toxicity to normal
cells of IEC-6. CTLEW from walnut by-products could
be as an anticancer peptide.
To assess the immunomodulatory activity of CTLEW,
spleen lymphocyte and macrophage functions were exam-
ined. MTT assay of spleen lymphocyte cultured in the
medium with or without CTLEW showed that it enhanced
the cells proliferation at all concentrations, showed immu-
nostimulatory activity in a dose-independent manner
(Fig. 7a). The effect of CTLEW on IL-2 production by
spleen lymphocyte was measured by ELISA. Compared
with control, IL-2 production of spleen lymphocyte treated
by the peptide significantly increased (Fig. 7b). In line with
the spleen lymphocyte proliferation results, CTLEW exhib-
ited immunostimulatory effect on spleen lymphocyte.
Phagocytosis and NO production were the main channels
for macrophages to play the immunological effect. To de-
termine the effect of the peptide on the phagocytic activity
of macrophage, the neutral red uptake assay was per-
formed. Macrophages incubated in culture medium with or
without the active peptide for 48 h were used to test the






Fig. 3 Isolation of bioactive peptides with cytotoxic activity on MCF-7 cells. a IC50 value of WRPH-pa with different molecular weights on MCF-7 cell
proliferation. b Gel filtration chromatography of WRPH-pa with <3 kDa molecular weights on a HiPrep 16/60 Sephacryl S-100HR column. Insets show
the IC50 value of fraction I to V on MCF-7 cell proliferation. c RP-HPLC chromatography of fraction V from gel chromatography. Insets show the IC50
value of fraction A to D on MCF-7 cell proliferation. d, e Identification of fraction C by TOF-LC/MS/MS coupled with ESI source. d Amino acid sequence
analysis of the bioactive peptide. e Molecular mass analysis of the bioactive peptide. Results were expressed as means ± S.D. of four
separate experiments
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Fig. 4 Effect of CTLEW on cell cycle distribution in MCF-7 cells. After treated with CTLEW (0, 0.5, 1.0 mg/ml) for 48 h, cells were stained by propidium
iodide. The fluorescence of stained cells was analyzed by flow cytometry. a control (0 mg/ml of CTLEW); (b) 0.5 mg/ml of CTLEW; (c) 1.0 mg/ml of
CTLEW. Data analysis was performed with ModFit LTTM cell cycle analysis software
a
b
Fig. 5 Induction of apoptosis cell death by CTLEW in MCF-7 cells. a Annexin V-FITC/PI doubles staning assay. Cells were treated with (0.5 or 1.0 mg/ml)
or without (control) CTLEW for 48 h, and were stained by annexinV-FITC/PI, respectively. Phosphotidylserine externalization in MCF-7 cells was determined
by flow cytometry of annexinV-FITC/PI stained cells. b TUNEL apoptosis assay. Cells were treated with (0.5 or 1.0 mg/ml) or without (control) CTLEW for
48 h, cell tissue slice was labelled by digoxigenin and observed by immunocytochemical staining, the labelled yellow brown nucleus represents the
apoptosis cells. Data were presented as mean ± S.D. of three separate experiments
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significant activity of promoting macrophages to devour
neutral red. NO production of the cells was determined by
Griess assay. After cells were incubated with CTLEW for
24 h, NO level of the experimental groups was significantly
elevated compared to the control group (Fig. 7d). These re-
sults indicated that the anticancer peptide also possessed
potential immunomodulatory effect.
Discussions
Generally, bioactive peptides are inactive within the se-
quences of their parent proteins, and need to be released
through enzymatic hydrolysis [11, 16]. A wide variety of
smaller peptides are generated via hydrolysis, depending
on enzyme specificity and hydrolytic time [2]. The differ-
ence of enzymes selected usually leads the hydrolysates to
have different qualities and bioactivities due to different
amino acid sequences and peptide lengths [18]. In this
study, walnut residual protein did not show any impair
towards MCF-7 cancer cell growth, but its hydrolsates
formed by commercial proteases including papain, pepsin,
trypsin, neutral protease and alkaline protease exhibited
inhibitory activity against the tumor cell lines. Compared
to hydrolyzed walnut residual proteins from other four
enzymes, papain-derived hydrolysates exhibited the stron-
gest cytotoxic activity. It is clear that the anticancer peptide
contained in walnut residual protein can be released and
well-prepared by papain hydrolysis. The optimized condi-
tions for the manufacture of the walnut residual protein
hydrolysates which have higher cytotoxic activity against
MCF-7 cells by papain are 5 % substrate concentration and
an enzyme-substrate ratio of 10 % at temperature 60 °C for
3 h incubation time.
Papain as an active endolytic cysteine protease does
not exhibit a broad specificity for peptide bonds, but ex-
hibits a preference in an amino acid bearing a large
hydrophobic side chain [34, 35]. Thus, the amino acid
sequence of the active peptide isolated from the papain-
forming hydrolysates is obtained as CTLEW throughout
sequential ultra-filtration, gel filtration chromatography
and RP-HPLC. C (Cys) is a hydrophilic amino acid, and
W (Trp) is a hydrophobic amino acid. Cys and Trp
arranged in two sides of the peptide of CTLEW form
clear hydrophilic and hydrophobic surfaces. Obviously,
CTLEW is a peptide with an amphiphilic structure. Our
results of MTT assay on Caco-2, Hela and IEC-6 cells
indicated that CTLEW could kill cancer cells selectively,
and was less toxicity to normal cells of IEC-6. The high
a
b
Fig. 6 Induction of autophagic cell death by CTLEW in MCF-7 cells.
a Western blotting of LC3I/II. Cells were treated with (0.1, 0.5, and
1.0 mg/ml) or without (control) CTLEW for 48 h, and expression of
LC3I/II in MCF-7 cells was detected by Western blotting. GAPDH was
used as internal control and RAPA was used as a positive control. b Im-
munofluorescence for LC3-II. Cells were treated with (1.0 mg/ml) or
without (control) CTLEW for 48 h, and formation of autophagic vacu-
oles was detected by immunofluorescent staining for LC3-II. RAPA was
used as a positive control. Blue, DAPI-stained cell nuclei; Green, LC3-II-
stained cytoplasm (100x magnification). Fluorescence intensity repre-
sents the expression of LC3-II. Data were presented as mean ± S.D. of
three separate experiments. *p < 0.05; **p < 0.01; ***p < 0.001, signifi-
cantly different from the respective control group
Table 2 Effect of CTLEW on other cancer and normal cell lines
Cell lines Hela Caco-2 IEC-6 spleen lymphocytes
IC50/(mg/mL) *0.60 ± 0.17 *0.65 ± 0.42 *>4 *>4
*After treated with CTLEW(0.5,1,2,3,4 mg/ml) for 48 h, cell viability was
measured by MTT assay. The IC50 value is the concentration that inhibits 50 %
of the cell viability, compared with control(untreated with CTLEW)
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amphipathic tend to be the heart of anticancer activity
[17]. The amphiphilic structure is conducive for the
membrane binding of anticancer peptides [36]. Amphi-
philicity levels and hydrophobic arc size are of major im-
portance to the ability of these peptides to invade cancer
cell membranes [37]. W (Trp) arranged in the sides of
the active peptide is the amino acid with higher hydro-
phobic arc size. It is reported that the spatial position
and arrangement of tryptophanes (W) affect membrane-
active peptide adsorption and activity [38, 39] and tryp-
tophanes have been observed to modulate hydrophobic
mismatches to maintain peptide stability and activity in
lipid bilayer membranes [40]. In addition, anticancer
peptides are generally stabilized by the disulfide bonds.
Defensins, lactoferricin, and tachyplesin are constrained
by disulfide bonds [17]. C (Cys) residues create a disul-
fide bond linking the highly positively charged NH2-
terminal region and the COOH-terminal region of the
peptide [41]. Taken together,CTLEW peptide isolated
from walnut residual protein by papain hydrolysis is an
amphiphilic structure,might be conducive to invade can-
cer cell membranes, and might be possessed higher hydro-
phobic arc size and stabilized by the disulfide bonds due
to C and W arranged in two sides of the active peptide.
CTLEW from walnut residual protein should be regarded
as a novel anticancer peptide, science it has not been
reported so far.
To investigate the possible mechanism underlying cyto-
toxic activity of CTLEW on growth of MCF-7 cells, Cell
cycle distribution, Annexin V FITC/ PI double-staining
and TUNEL assay were performed. CTLEW significantly
increased the number of cells in sub-G1 phase, induced
phosphatidylserine externalization without increasing the
proportion of propidium iodide cells, implicating that it
induced apoptosis. Apoptosis was further confirmed by
TUNEL assay observed the apoptotic cells. Besides
A B
Fig. 7 Immunomodulatory activity of CTLEW. a Effects of CTLEW on mouse spleen lymphocytes proliferation. Cells were pretreated with (0.5, 1, 2, 3,
4 mg/ml) or without (control) CTLEW for 48 h. Con A (10 μg/ml) was used as a positive control. Cell viability was measured by MTT assay. b Effects of
CTLEW on IL-2 cytokine production in mouse spleen lymphocytes. Cells were cultured for 24 h in the media with (0.5 mg/ml) or without (control) CTLEW.
ConA (10 μg/ml) was used as a positive control. The amounts of IL-2 released into the culture media were measured by immunoassays. c Effect of
CTLEW on phagocytosis of macrophages by neutral red uptake assay. After treated with (0.5 mg/ml) or without (control) CTLEW for 48 h, macrophage
phagocytosis was determined by Neutral red uptake assay. LPS (1 μg/ml) was used as a positive control. (D), Effect of CTLEW on the NO production of
macrophages. Cells were pretreated with (0.5 mg/ml) or without (control) CTLEW for 24 h. LPS (1 μg/ml) was used as a positive control. The supernatant
nitrite levels were determined using Griess reagent. Results were expressed as means ± S.D. of four separate experiments. Statistical significance test for
comparison with untreated group was done by Student’s t-test. *p < 0.05; **p < 0.01, ***p < 0.001
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apoptosis, autophagy has been described as an alternative
self-destructive cellular process, which is linked to cancer
cell death [42]. Apoptotic and autophagic cell death are
not mutually exclusive pathways, they could induce cell
death simultaneously and cooperatively [42, 43]. Apoptotic
process could be controlled by autophagy to be more prob-
able, and vice versa [44]. Autophagy, an evolutionarily
conserved process, regulates cell death in both physio-
logical and pathophysiological conditions, in which
cytoplasmic components including entire organelles are
targeted for lysosomal degradation [45, 46]. The micro-
tubule associated protein 1 light chain 3 (LC3) plays a
critical role in autophagy [46, 47]. It normally resides in the
cytoplasm as LC3-I, which associates with autophagosomal
membranes during macroautophagy after modification
to LC3-II by attachment of phosphatidylethanolamine
[48, 49]. The conversion of the soluble form of LC3-I
to the autophagic vesicle-associated form LC3-II is
considered a specific marker of autophagosome pro-
motion [50]. Therefore LC3-II is one of the principle
cell death markers that correlate with the extent of
autophagy [24, 26]. LC3I/II was determined by western
blot analysis, CTLEW significantly increased the level of
phosphatidylethanolamine-conjugated LC3-II, whereas
unconjugated LC3-I levels were slightly decreased, indicat-
ing the active peptide induced autophagic cell death.
Autophagy was further confirmed by immunofluorescence
for LC3-II. CTLEW exhibited cytotoxic activity on cancer
cells by inducing apoptosis and autophagy.
Autophagy is a caspase independent cell death pathway
[51], and co-activation of autophagy and caspase independ-
ent apoptosis has been documented in various biological
contexts [52–54]. Anticancer Peptide FK-16 induced
caspase-independent apoptosis and autophagy through the
common p53-Bcl-2/Bax cascade in colon cancer cells [26].
In the present study, the apoptosis induced by CTLEW
might be a caspase independent cell death pathway
induced by the decrease in mitochondrial membrane po-
tential and release of cytochrome c from mitochondria to
cytosol [55]. In another hand, several studies established
nitric oxide NO as an effector of apoptosis [53, 54]. Our
results of Griess assay showed that production of intracel-
lular NO in MCF-7 cells treated with CTLEW was
increased in a dose-dependent manner (data not shown).
NO, as a free-radical gas, is synthesized by inducible nitric
oxide synthase (iNOS) [56]. Secretion of NO was through
stimulating intracellular signaling molecules such as
MAPKs [57]. Earlier reports suggest that JNK signaling is
of primary importance in controlling iNOS expression.
Avik et al. report suggested that iNOS- mediated produc-
tion of NO was identified as an effector molecule causing
apoptosis of cancer cells, expression of iNOS was induced
by activation of JNK and ERK subsequently [55]. CTLEW
inducing apoptosis and autophagy might be in caspase
independent manner, and nitric oxide NO might be as an
effector of apoptosis.
Recent studies have revealed immunomodulatory proper-
ties of anticancer peptide from soybean,frog skin and other
food [9, 58]. The results of immunocyte functions assay
showed that the anticancer peptide enhanced proliferation
and IL-2 secretion of spleen lymphocytes, promoted phago-
cytosis and NO production of macrophages, suggesting the
anticancer peptide revealed immunostimulatory effect. Pre-
vious studies have shown that antioxidants, such as peptide
isolated in soybean, lunasin [9] or phenolics from emblica
fruit [59] possessed anticancer and immunomodulatory ac-
tivity simultaneously, because cancer cells have long been
known to have higher oxidative stress than their normal
counterparts [55]. However, manipulation of intracellular
oxidative stress either by antioxidants [60] or by pro-
oxidants [61, 62] has also been exploited for preferential
killing of cancer cells. To investigate the antioxidant activity
of the active peptide, DPPH, hydroxyl radical scavenging
and reducing power assays of CTLEW were performed.
However, the results showed that the active peptide did not
reveal antioxidant activity (data not shown), indicating that
the anticancer and immunomodulatory activity were not
associated with the antioxidant effect.
Conclusions
This work uses papain firstly to degrade WRP to produce
anticancer peptide. The anticancer peptide is a novel bio-
peptide with the amino acid sequence CTLEW, and its
molecular weight is 651.2795 Da with an amphiphilic
structure. CTLEW shows a selective inhibition towards
cancer cells by inducing apoptosis and autophagy, and is
less toxicity to non-cancerous cells. Moreover, the bio-
peptide indicates potential immunomodulatory effect. The
optimized conditions for the release of CTLEW from
WRP are 5 % substrate concentration and an enzyme-
substrate ratio of 10 % at temperature 60 °C for 3 h incu-
bation time. These results suggested that WRP from oil
process can be applied to produce an anticancer peptide
via adequate hydrolysis, the hydrolysates and/or its iso-
lated peptides may be effectively used as functional food
ingredients and/or pharmaceuticals.
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